id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0195-0005,FDA,FDA-2001-D-0195,Blood Products Advisory Committee - Transcript (100-195 pgs),Other,TR-Transcript,2008-04-24T04:00:00Z,2008,4,2008-04-24T04:00:00Z,,2024-11-07T21:53:14Z,,1,0,09000064804e2dba
FDA-2001-D-0195-0004,FDA,FDA-2001-D-0195,Blood Products Advisory Committee - Transcript (1-100 pgs),Other,TR-Transcript,2008-04-24T04:00:00Z,2008,4,2008-04-24T04:00:00Z,,2024-11-07T21:53:14Z,,1,0,09000064804e2db5
FDA-2001-D-0195-0003,FDA,FDA-2001-D-0195,HFM-300 - Hearing Order,Other,OR-Order,2008-04-24T04:00:00Z,2008,4,2008-04-24T04:00:00Z,,2008-04-25T02:27:20Z,,0,0,09000064804e2db2
FDA-2001-D-0195-0011,FDA,FDA-2001-D-0195,Reference - Guidance for Industry,Supporting & Related Material,REF-Reference (internal unless indicated),2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2e67
FDA-2001-D-0195-0010,FDA,FDA-2001-D-0195,Reference - FDA Publivcation,Supporting & Related Material,REF-Reference (internal unless indicated),2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2e57
FDA-2001-D-0195-0007,FDA,FDA-2001-D-0195,Guidance - FDA,Supporting & Related Material,GDL-Guidance,2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2e41
FDA-2001-D-0195-0008,FDA,FDA-2001-D-0195,Reference - FDA Publication,Supporting & Related Material,REF-Reference (internal unless indicated),2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2e4a
FDA-2001-D-0195-0009,FDA,FDA-2001-D-0195,Reference - FDA Publication,Supporting & Related Material,REF-Reference (internal unless indicated),2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2e4f
FDA-2001-D-0195-0006,FDA,FDA-2001-D-0195,Guidance - Draft,Supporting & Related Material,GDL-Guidance,2008-04-24T04:00:00Z,2008,4,,,2008-04-25T02:27:20Z,,0,0,09000064804e2d90
FDA-2001-D-0195-0002,FDA,FDA-2001-D-0195,FDA,Notice,NAD-Notice of Availability of Data,2007-08-08T04:00:00Z,2007,8,2007-08-08T04:00:00Z,2008-08-09T03:59:59Z,2008-05-30T22:48:32Z,,0,0,09000064804e2e45
FDA-2001-D-0195-0001,FDA,FDA-2001-D-0195,FDA,Notice,NAD-Notice of Availability of Data,2001-09-05T04:00:00Z,2001,9,2001-09-05T04:00:00Z,2001-10-30T04:59:59Z,2008-05-30T22:48:32Z,,0,0,09000064804e2d49